D
Atai Life Sciences N.V. ATAI
$4.74 -$0.0899-1.86% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -105.62% -340.76% -271.09% -92.11% 59.97%
Total Depreciation and Amortization 120.88% 79.82% 48.28% 28.78% 45.92%
Total Amortization of Deferred Charges 25.63% 46.25% 38.81% 5.71% 29.61%
Total Other Non-Cash Items 291.99% 248.21% 244.17% 284.89% -154.33%
Change in Net Operating Assets -218.13% -390.87% -223.18% -421.22% 75.83%
Cash from Operations 4.57% 9.20% 2.00% 13.55% 22.57%
Capital Expenditure -14,287.50% -4,976.19% 97.68% 97.96% 99.06%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- 200.00% --
Divestitures -- -- -- -- --
Other Investing Activities 262.23% 165.05% 211.84% 81.91% -113.54%
Cash from Investing 254.43% 163.43% 211.03% 87.78% -113.94%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 23,088.41% 319,394.74% 137.78% 21.21% -94.06%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -48.47% 91.55% 98.12% -654.01% -359.62%
Cash from Financing 990.10% 859.01% 164.32% -297.18% -142.89%
Foreign Exchange rate Adjustments 453.70% 1,447.06% 91.53% 118.00% -29.41%
Miscellaneous Cash Flow Adjustments -- 200.00% -- -- --
Net Change in Cash 125.86% 116.06% 87.96% 52.26% -287.43%